11:44 AM EST - Sernova Corp. : Announced that patient screening and recruitment has begun in its regenerative medicine U.S. clinical trial for diabetic patients with hypoglycemia unawareness. Sernova Corp.
shares V.SVA are trading up $0.005 at $0.24.
